{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:14:14Z","timestamp":1762542854932,"version":"build-2065373602"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,5,21]],"date-time":"2018-05-21T00:00:00Z","timestamp":1526860800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ajoc.2018.05.006","type":"journal-article","created":{"date-parts":[[2018,5,22]],"date-time":"2018-05-22T02:20:55Z","timestamp":1526955655000},"page":"66-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"special_numbering":"C","title":["Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity"],"prefix":"10.1016","volume":"11","author":[{"given":"Yoko","family":"Fukushima","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shunji","family":"Kusaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshikazu","family":"Hatsukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8838-7593","authenticated-orcid":false,"given":"Kohji","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"26","key":"10.1016\/j.ajoc.2018.05.006_bib1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1056\/NEJMra1208129","article-title":"Mechanisms and management of retinopathy of prematurity","volume":"367","author":"Hartnett","year":"2012","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.ajoc.2018.05.006_bib2","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1001\/archopht.1996.01100130413008","article-title":"Multicenter trial of cryotherapy for retinopathy of prematurity. Snellen visual acuity and structural outcome at 5 1\/2 years after randomization. Cryotherapy for Retinopathy of Prematurity Cooperative Group","volume":"114","author":"Trial","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"6","key":"10.1016\/j.ajoc.2018.05.006_bib3","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1001\/archophthalmol.2010.72","article-title":"Final visual acuity results in the early treatment for retinopathy of prematurity study","volume":"128","author":"Early Treatment for Retinopathy of Prematurity Cooperative Group","year":"2010","journal-title":"Arch Ophthalmol"},{"issue":"2","key":"10.1016\/j.ajoc.2018.05.006_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.earlhumdev.2007.11.009","article-title":"Retinopathy of prematurity: a global perspective of the epidemics, population of babies at risk and implications for control","volume":"84","author":"Gilbert","year":"2008","journal-title":"Early Hum Dev"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1542\/peds.2012-2996","article-title":"Screening examination of premature infants for retinopathy of prematurity","volume":"131","author":"Fierson","year":"2013","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajoc.2018.05.006_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1038\/pr.2012.114","article-title":"Trends in morbidity and mortality among very-low-birth-weight infants from 2003 to 2008 in Japan","volume":"72","author":"Kusuda","year":"2012","journal-title":"Pediatr Res"},{"issue":"4","key":"10.1016\/j.ajoc.2018.05.006_bib7","doi-asserted-by":"crossref","first-page":"e957","DOI":"10.1542\/peds.2012-0336","article-title":"Comparison of mortality and morbidity of very low birth weight infants between Canada and Japan","volume":"130","author":"Isayama","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/j.ajoc.2018.05.006_bib8","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.jpeds.2017.05.017","article-title":"Early mortality and morbidity in infants with birth weight of 500\u2009Grams or less in Japan","volume":"190","author":"Inoue","year":"2017","journal-title":"J Pediatr"},{"issue":"4 Suppl","key":"10.1016\/j.ajoc.2018.05.006_bib9","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1097\/IAE.0b013e3181cb6151","article-title":"Aggressive posterior retinopathy of prematurity","volume":"30","author":"Drenser","year":"2010","journal-title":"Retina"},{"issue":"7","key":"10.1016\/j.ajoc.2018.05.006_bib10","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1001\/archopht.123.7.991","article-title":"The international classification of retinopathy of prematurity revisited","volume":"123","author":"ICROP. International Committee for the Classification of Retinopathy of Prematurity","year":"2005","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajoc.2018.05.006_bib11","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1007374","article-title":"Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity","volume":"364","author":"Mintz-Hittner","year":"2011","journal-title":"N Engl J Med"},{"issue":"5","key":"10.1016\/j.ajoc.2018.05.006_bib12","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.ophtha.2016.12.025","article-title":"Anti-vascular endothelial growth factor therapy for primary treatment of type 1 retinopathy of prematurity: a report by the american academy of ophthalmology","volume":"124","author":"VanderVeen","year":"2017","journal-title":"Ophthalmology"},{"issue":"4","key":"10.1016\/j.ajoc.2018.05.006_bib13","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-3218","article-title":"Neurodevelopmental outcomes following bevacizumab injections for retinopathy of prematurity","volume":"137","author":"Morin","year":"2016","journal-title":"Pediatrics"},{"issue":"5","key":"10.1016\/j.ajoc.2018.05.006_bib14","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/ceo.12280","article-title":"Prevalence and outcomes of laser treatment of aggressive posterior retinopathy of prematurity","volume":"42","author":"Gunn","year":"2014","journal-title":"Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajoc.2018.05.006_bib15","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1136\/bjo.2008.140657","article-title":"Efficacy of intravitreal injection of bevacizumab for severe retinopathy of prematurity: a pilot study","volume":"92","author":"Kusaka","year":"2008","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"10.1016\/j.ajoc.2018.05.006_bib16","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.ophtha.2004.02.005","article-title":"Involution of threshold retinopathy of prematurity after diode laser photocoagulation","volume":"111","author":"Coats","year":"2004","journal-title":"Ophthalmology"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib17","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ajo.2012.07.012","article-title":"Aggressive posterior retinopathy of prematurity: risk factors for retinal detachment despite confluent laser photocoagulation","volume":"155","author":"Sanghi","year":"2013","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2018.05.006_bib18","doi-asserted-by":"crossref","first-page":"2130","DOI":"10.1097\/IAE.0000000000000604","article-title":"Comparing the outcome of single versus multiple session laser photoablation of flat neovascularization in zone 1 aggressive posterior retinopathy of prematurity: a prospective randomized study","author":"Vinekar","year":"2015","journal-title":"Retina"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib19","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.optom.2012.08.004","article-title":"Intravitreal anti-VEGF therapy as an adjunct to laser photocoagulation for severe aggressive posterior retinopathy of prematurity","volume":"6","author":"Ozdek","year":"2013","journal-title":"J. Optom."},{"issue":"2","key":"10.1016\/j.ajoc.2018.05.006_bib20","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/j.1755-3768.2011.02351.x","article-title":"Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?","volume":"91","author":"Spandau","year":"2013","journal-title":"Acta Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib21","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-12264-z","article-title":"Ranibizumab after laser photocoagulation failure in retinopathy of prematurity (ROP) treatment","volume":"7","author":"Gotz-Wi\u0229ckowska","year":"2017","journal-title":"Sci Rep"},{"issue":"10","key":"10.1016\/j.ajoc.2018.05.006_bib22","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1016\/j.ophtha.2016.06.055","article-title":"Chronic vascular arrest as a predictor of bevacizumab treatment failure in retinopathy of prematurity","volume":"123","author":"Toy","year":"2016","journal-title":"Ophthalmology"},{"issue":"9","key":"10.1016\/j.ajoc.2018.05.006_bib23","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1016\/j.ophtha.2016.04.028","article-title":"Clinical management of recurrent retinopathy of prematurity after intravitreal bevacizumab monotherapy","volume":"123","author":"Mintz-Hittner","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ajoc.2018.05.006_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bjophthalmol-2016-308375","article-title":"Treatment of type I ROP with intravitreal bevacizumab or laser photocoagulation according to retinal zone","author":"Mueller","year":"2016","journal-title":"Br J Ophthalmol"},{"issue":"8947","key":"10.1016\/j.ajoc.2018.05.006_bib25","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(95)90425-5","article-title":"Follow-up of preterm children: important to document dropouts","volume":"345","author":"Wolke","year":"1995","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.ajoc.2018.05.006_bib26","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1001\/archpediatrics.2011.616","article-title":"Relationship between attrition and neurodevelopmental impairment rates in extremely preterm infants at 18 to 24 months","volume":"166","author":"Guill\u00e9n","year":"2012","journal-title":"Arch Pediatr Adolesc Med"},{"issue":"6","key":"10.1016\/j.ajoc.2018.05.006_bib27","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1213\/ANE.0000000000000705","article-title":"Outcomes for extremely premature infants","volume":"120","author":"Glass","year":"2015","journal-title":"Anesth Analg"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib28","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1474-4422(08)70294-1","article-title":"Brain injury in premature infants: a complex amalgam of destructive and developmental disturbances","volume":"8","author":"Volpe","year":"2009","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1016\/j.ajoc.2018.05.006_bib29","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/IAE.0000000000001125","article-title":"Outcomes after laser versus combined laser and bevacizumab treatment for type 1 retinopathy of prematurity in zone I","volume":"37","author":"Yoon","year":"2017","journal-title":"Retina"},{"issue":"2","key":"10.1016\/j.ajoc.2018.05.006_bib30","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1167\/iovs.14-15842","article-title":"Pharmacokinetics of bevacizumab and its effects on serum vegf and igf-1 in infants with retinopathy of prematurity","volume":"56","author":"Kong","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"10.1016\/j.ajoc.2018.05.006_bib31","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1038\/sj.eye.6702838","article-title":"Ophthalmological problems associated with preterm birth","volume":"21","author":"O'Connor","year":"2007","journal-title":"Eye"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618300124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993618300124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T14:57:45Z","timestamp":1762527465000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993618300124"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":31,"alternative-id":["S2451993618300124"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.05.006","relation":{},"ISSN":["2451-9936"],"issn-type":[{"type":"print","value":"2451-9936"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Favorable outcomes of adequate laser photocoagulation and salvage bevacizumab treatment for aggressive posterior retinopathy of prematurity","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2018.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}